Neo Ivy Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $657K | Buy |
+14,187
| New | +$657K | 0.21% | 166 |
|
|
2023
Q3 | – | Sell |
-13,098
| Closed | -$838K | – | 331 |
|
|
2023
Q2 | $838K | Buy |
+13,098
| New | +$838K | 0.44% | 82 |
|
|
2022
Q4 | $964K | Buy |
+13,404
| New | +$964K | 0.65% | 30 |
|
|
2022
Q2 | – | Sell |
-4,872
| Closed | -$356K | – | 413 |
|
|
2022
Q1 | $356K | Buy |
4,872
+2,965
| +155% | +$217K | 0.32% | 119 |
|
|
2021
Q4 | $119K | Buy |
+1,907
| New | +$119K | 0.17% | 203 |
|
|
2021
Q2 | – | Sell |
-1,893
| Closed | -$120K | – | 457 |
|
|
2021
Q1 | $120K | Buy |
+1,893
| New | +$120K | 0.13% | 218 |
|
|
2020
Q4 | – | Sell |
-7,999
| Closed | -$482K | – | 424 |
|
|
2020
Q3 | $482K | Buy |
+7,999
| New | +$482K | 0.49% | 48 |
|
|
2020
Q2 | – | Sell |
-1,353
| Closed | -$75K | – | 467 |
|
|
2020
Q1 | $75K | Buy |
+1,353
| New | +$75K | 0.12% | 252 |
|
|
2019
Q4 | – | Sell |
-621
| Closed | -$30K | – | 271 |
|
|
2019
Q3 | $30K | Sell |
621
-31,329
| -98% | -$1.51M | 0.02% | 252 |
|
|
2019
Q2 | $1.45M | Buy |
31,950
+13,761
| +76% | +$624K | 0.82% | 3 |
|
|
2019
Q1 | $867K | Buy |
+18,189
| New | +$867K | 0.49% | 89 |
|